{"id":17081,"date":"2026-09-01T06:00:31","date_gmt":"2026-09-01T06:00:31","guid":{"rendered":"https:\/\/nextrove.com\/?p=17081"},"modified":"2026-09-01T10:18:56","modified_gmt":"2026-09-01T10:18:56","slug":"nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments","status":"publish","type":"post","link":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/","title":{"rendered":"Nextrove Regulatory Bulletin Issue 2: Navigating the Latest Global Pharmacovigilance Developments"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;bottom&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;481527&#8243;][vc_column_text uncode_shortcode_id=&#8221;183430&#8243;]Nextrove has released <strong>Issue 2 \u2013 Q3 2026 of its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin<\/strong>, providing an overview of key regulatory developments shaping pharmacovigilance and drug safety requirements worldwide.<\/p>\n<p>A major focus of this edition is the implementation of <strong>ICH E2D(R1)<\/strong> and its evolving impact on post-approval safety data management. The revised framework introduces important clarifications around Organized Data Collection Systems (ODCS), including patient support programs, market research activities and digital sources, with implications for case classification, documentation, reporting processes and pharmacovigilance oversight.<\/p>\n<p>The bulletin examines developments across multiple regulatory regions, including the <strong>European Union and United States<\/strong>, while also covering important updates from the <strong>United Kingdom, Singapore, Saudi Arabia, Australia and South Africa<\/strong>.<\/p>\n<p>Other topics featured in Issue 2 include changes to clinical trial safety reporting requirements, the use of AI in GxP inspection responses, post-approval pregnancy safety studies, real-world data and evidence, pharmacovigilance considerations for advanced therapy medicinal products, and the continued evolution of electronic safety reporting.<\/p>\n<p>With regulatory expectations continuing to evolve across markets, understanding not only what has changed but also its potential operational impact is increasingly important for maintaining effective and compliant pharmacovigilance systems.<\/p>\n<p><strong>Explore Issue 2 of the Nextrove Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin to stay informed and prepare for what\u2019s ahead.<\/strong>[\/vc_column_text][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;208605&#8243;][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; back_color=&#8221;accent&#8221; overlay_alpha=&#8221;50&#8243; radius=&#8221;std&#8221; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;263158&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_button size=&#8221;btn-lg&#8221; border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fnextrove.com%2Fwp-content%2Fuploads%2F2026%2F08%2FNXT_BULLETIN_02Q3.pdf|target:_blank&#8221; uncode_shortcode_id=&#8221;110760&#8243;]DOWNLOAD NEXTROVE REGULATORY BULLETIN ISSUE 2[\/vc_button][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][vc_separator sep_color=&#8221;color-vyce&#8221; uncode_shortcode_id=&#8221;945272&#8243; sep_color_type=&#8221;uncode-palette&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin<\/p>\n","protected":false},"author":1,"featured_media":17087,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"categories":[79],"tags":[],"class_list":["post-17081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nextrove Regulatory Bulletin Issue 2<\/title>\n<meta name=\"description\" content=\"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nextrove Regulatory Bulletin Issue 2\" \/>\n<meta property=\"og:description\" content=\"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/\" \/>\n<meta property=\"og:site_name\" content=\"Nextrove\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T06:00:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T10:18:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\"},\"headline\":\"Nextrove Regulatory Bulletin Issue 2: Navigating the Latest Global Pharmacovigilance Developments\",\"datePublished\":\"2026-09-01T06:00:31+00:00\",\"dateModified\":\"2026-09-01T10:18:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/\"},\"wordCount\":393,\"image\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260901-bulletin02.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/\",\"url\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/\",\"name\":\"Nextrove Regulatory Bulletin Issue 2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260901-bulletin02.jpg\",\"datePublished\":\"2026-09-01T06:00:31+00:00\",\"dateModified\":\"2026-09-01T10:18:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\"},\"description\":\"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260901-bulletin02.jpg\",\"contentUrl\":\"https:\\\/\\\/nextrove.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/20260901-bulletin02.jpg\",\"width\":1672,\"height\":941},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nextrove Regulatory Bulletin Issue 2: Navigating the Latest Global Pharmacovigilance Developments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/#website\",\"url\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/\",\"name\":\"Nextrove\",\"description\":\"Empowering Clients to Improve Patient Safety\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/#\\\/schema\\\/person\\\/537142fb2f0051496524c2a926802eab\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/nextrove.com\\\/ja\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nextrove Regulatory Bulletin Issue 2","description":"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/","og_locale":"ja_JP","og_type":"article","og_title":"Nextrove Regulatory Bulletin Issue 2","og_description":"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin","og_url":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/","og_site_name":"Nextrove","article_published_time":"2026-09-01T06:00:31+00:00","article_modified_time":"2026-09-01T10:18:56+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"admin","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#article","isPartOf":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/"},"author":{"name":"admin","@id":"https:\/\/nextrove.com\/ja\/#\/schema\/person\/537142fb2f0051496524c2a926802eab"},"headline":"Nextrove Regulatory Bulletin Issue 2: Navigating the Latest Global Pharmacovigilance Developments","datePublished":"2026-09-01T06:00:31+00:00","dateModified":"2026-09-01T10:18:56+00:00","mainEntityOfPage":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/"},"wordCount":393,"image":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg","articleSection":["News"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/","url":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/","name":"Nextrove Regulatory Bulletin Issue 2","isPartOf":{"@id":"https:\/\/nextrove.com\/ja\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#primaryimage"},"image":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg","datePublished":"2026-09-01T06:00:31+00:00","dateModified":"2026-09-01T10:18:56+00:00","author":{"@id":"https:\/\/nextrove.com\/ja\/#\/schema\/person\/537142fb2f0051496524c2a926802eab"},"description":"To help organizations stay ahead of the rapidly evolving global regulatory landscape, Nextrove is introducing its Quarterly Pharmacovigilance and Regulatory Intelligence Bulletin","breadcrumb":{"@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#primaryimage","url":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg","contentUrl":"https:\/\/nextrove.com\/wp-content\/uploads\/2026\/08\/20260901-bulletin02.jpg","width":1672,"height":941},{"@type":"BreadcrumbList","@id":"https:\/\/nextrove.com\/ja\/nextrove-regulatory-bulletin-issue-2-navigating-the-latest-global-pharmacovigilance-developments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nextrove.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Nextrove Regulatory Bulletin Issue 2: Navigating the Latest Global Pharmacovigilance Developments"}]},{"@type":"WebSite","@id":"https:\/\/nextrove.com\/ja\/#website","url":"https:\/\/nextrove.com\/ja\/","name":"Nextrove","description":"Empowering Clients to Improve Patient Safety","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nextrove.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/nextrove.com\/ja\/#\/schema\/person\/537142fb2f0051496524c2a926802eab","name":"admin","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/268304982f799bf80602918d742ac9b9329f13bdddc22677ace45bb50f305bcb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/nextrove.com\/ja\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/posts\/17081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/comments?post=17081"}],"version-history":[{"count":1,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/posts\/17081\/revisions"}],"predecessor-version":[{"id":17086,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/posts\/17081\/revisions\/17086"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/media\/17087"}],"wp:attachment":[{"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/media?parent=17081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/categories?post=17081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nextrove.com\/ja\/wp-json\/wp\/v2\/tags?post=17081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}